• Severe systemic infections, including sepsis and bacteremia
• Lower respiratory tract infections
• Complicated urinary tract infections
• Bacterial eye infections (ophthalmic formulations)
• Pseudomonas aeruginosa infections in cystic fibrosis patients

Tocin 80mg Injection acts by binding to bacterial ribosomes, specifically the 30S subunit, disrupting protein synthesis. This mechanism stops bacterial growth and leads to cell death, effectively clearing the infection. Its high potency against Gram-negative bacteria and limited resistance make it a reliable choice for treating severe infections. Tobramycin is also effective in reducing bacterial load in localised infections, such as lung and eye infections.

Tocin 80mg Injection can interact with certain medications, leading to serious side effects or reduced efficacy. Key interactions include:

• Nephrotoxic drugs (e.g., vancomycin, amphotericin B): Increased risk of kidney damage.
• Ototoxic drugs (e.g., furosemide, cisplatin): Heightened chances of hearing loss or balance issues.
• Neuromuscular blocking agents: Can exacerbate muscle weakness or respiratory paralysis.
• Loop diuretics: Elevated risk of ototoxicity when co-administered.
• Nonsteroidal anti-inflammatory drugs (NSAIDs): Potential for reduced renal clearance of Tobramycin.

Always inform your healthcare provider about any ongoing medications to avoid adverse outcomes.

• Keep below 25°C in a dry place away from sunlight.
• Do not freeze.
• Take as soon as remembered unless it’s close to the next dose. Do not double the dose.

Tocin 80mg Injection, USP is supplied as a dry powder in a bulk package vial. The contents must be reconstituted with 30 mL of Sterile Water for Injection, USP, to prepare a solution containing 40 mg/mL of tobramycin. This solution must be further diluted prior to intravenous (IV) administration.

For adults, the recommended dosages are as follows:

• Serious infections: 3 mg/kg/day divided into three equal doses (1 mg/kg every 8 hours).
• Life-threatening infections: Up to 5 mg/kg/day divided into three or four doses.

Specific dosage recommendations are provided for pediatric patients, patients with cystic fibrosis, renal impairment, and obese patients. It is crucial to adhere to prescribing guidelines and consult full prescribing information for precise adjustments. Tobramycin is not intended for direct infusion in its bulk package form and must be dispensed through a pharmacy admixture program.

Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.

Common Side Effects:

• Nausea
• Vomiting
• Eye irritation (ophthalmic use)
• Mild dizziness

Serious Side Effects:

• Hearing loss
• Kidney damage
• Severe allergic reactions (rash, swelling, difficulty breathing)
• Muscle weakness

Report any severe side effects to a healthcare provider immediately.

Tocin 80mg Injection is a potent antibiotic that requires careful use under medical supervision. Regular monitoring of kidney function and hearing is essential during treatment. Patients with pre-existing kidney or ear conditions should exercise caution. Always complete the prescribed course, even if symptoms improve, to prevent antibiotic resistance. Consult a healthcare provider before starting or stopping the medication.

1. Reyhanoglu G, Reddivari AKR. Tobramycin. [Updated 2023 Aug 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551695/
2. National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 36294, Tobramycin. Retrieved December 19, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/Tobramycin.
3. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050789s012lbl.pdf